• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国初级医疗环境中肠易激综合征对健康相关生活质量及成本的影响

Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.

作者信息

Akehurst Ron L, Brazier John E, Mathers Nigel, O'Keefe Caroline, Kaltenthaler Eva, Morgan Anne, Platts Maria, Walters Stephen J

机构信息

School of Health and Related Research (ScHARR), University of Sheffield, Regent Court, Sheffield S1 4DA, United Kingdom.

出版信息

Pharmacoeconomics. 2002;20(7):455-62. doi: 10.2165/00019053-200220070-00003.

DOI:10.2165/00019053-200220070-00003
PMID:12093301
Abstract

OBJECTIVES

To identify the impact of irritable bowel syndrome (IBS) on health-related quality of life (HR-QOL), time off work and the utilisation and cost of health services.

DESIGN

A case-control study was undertaken matching patients with IBS and controls. Quality-of-life information was collected using the Medical Outcomes Study 36-item Short Form (SF-36) health survey, EuroQOL instrument (EQ-5D) and IBS Quality-of-Life (IBS-QOL) instruments. Data on time off work was also collected. National Health Service (NHS) resource use in primary and secondary care was estimated by review of general practitioner (GP) and hospital records over a 12-month period.

SETTING

Recruitment was from six GPs' surgeries in the Trent Region of the United Kingdom.

PARTICIPANTS

161 patients with IBS, as defined by the Rome Criteria I were recruited. These were compared with 213 controls matched for age, sex and social characteristics.

MAIN OUTCOME MEASURES

SF-36 and EQ-5D scores; mean number of days off work; mean NHS costs per person during the 12-month study period.

RESULTS

Patients with IBS had considerably lower HR-QOL than controls. They scored worse in all dimensions of the SF-36 and the EQ-5D and they had more time off work. On average patients with IBS cost the NHS 123 UK pounds (95% confidence interval: 35 UK pounds to 221 UK pounds, 1999 values) more per year than individuals in the control group (p = 0.04).

CONCLUSIONS

IBS affects patients through reduced quality of life, more time off work and greater healthcare utilisation than a control group of patients without IBS. The difference in quality of life was pronounced and unusual in that it was influential in every dimension of both the SF-36 and the EQ-5D.

摘要

目的

确定肠易激综合征(IBS)对健康相关生活质量(HR-QOL)、误工时间以及医疗服务利用和成本的影响。

设计

开展了一项病例对照研究,对IBS患者与对照进行匹配。使用医学结局研究36项简表(SF-36)健康调查、欧洲五维度健康量表(EQ-5D)和肠易激综合征生活质量量表(IBS-QOL)收集生活质量信息。还收集了误工时间数据。通过回顾12个月期间全科医生(GP)和医院记录来估算英国国家医疗服务体系(NHS)在初级和二级医疗保健中的资源使用情况。

地点

招募工作来自英国特伦特地区的六个全科医生诊所。

参与者

招募了161名符合罗马标准I定义的IBS患者。将这些患者与213名在年龄、性别和社会特征方面匹配的对照进行比较。

主要结局指标

SF-36和EQ-5D评分;平均误工天数;12个月研究期间每人的平均NHS成本。

结果

IBS患者的HR-QOL显著低于对照。他们在SF-36和EQ-5D的所有维度上得分都更低,且误工时间更长。平均而言,IBS患者每年比对照组个体多花费NHS 123英镑(95%置信区间:35英镑至221英镑,199年数值)(p = 0.04)。

结论

与无IBS的对照组患者相比,IBS通过降低生活质量、增加误工时间和更高的医疗服务利用率来影响患者。生活质量的差异很显著且不同寻常,因为它在SF-36和EQ-5D的每个维度上都有影响。

相似文献

1
Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting.英国初级医疗环境中肠易激综合征对健康相关生活质量及成本的影响
Pharmacoeconomics. 2002;20(7):455-62. doi: 10.2165/00019053-200220070-00003.
2
Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria.比较罗马I和罗马II标准的肠易激综合征的疾病负担
Pharmacoeconomics. 2002;20(11):749-58. doi: 10.2165/00019053-200220110-00004.
3
Performance of the EQ-5D in patients with irritable bowel syndrome.EQ-5D在肠易激综合征患者中的表现。
Value Health. 2006 Mar-Apr;9(2):90-7. doi: 10.1111/j.1524-4733.2006.00086.x.
4
Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.肠易激综合征对美国和英国生活质量及资源利用的影响。
Digestion. 1999 Jan-Feb;60(1):77-81. doi: 10.1159/000007593.
5
Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.腹泻型肠易激综合征患者的健康相关生活质量、工作效率及间接成本
Health Qual Life Outcomes. 2017 Feb 14;15(1):35. doi: 10.1186/s12955-017-0611-2.
6
Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome.重度难治性肠易激综合征患者的健康相关生活质量与医疗费用
Ann Intern Med. 2001 May 1;134(9 Pt 2):860-8. doi: 10.7326/0003-4819-134-9_part_2-200105011-00010.
7
Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.腹泻型肠易激综合征患者的疾病特异性生活质量低于便秘型肠易激综合征患者。
World J Gastroenterol. 2015 Jul 14;21(26):8103-9. doi: 10.3748/wjg.v21.i26.8103.
8
[An epidemiological and quality of life study of irritable bowel syndrome in Zhejiang province].[浙江省肠易激综合征的流行病学与生活质量研究]
Zhonghua Nei Ke Za Zhi. 2003 Jan;42(1):34-7.
9
Costs of care for irritable bowel syndrome patients in a health maintenance organization.健康维护组织中肠易激综合征患者的护理成本。
Am J Gastroenterol. 2001 Nov;96(11):3122-9. doi: 10.1111/j.1572-0241.2001.05258.x.
10
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.罗马IV型肠易激综合征中与较低疾病特异性和一般健康相关生活质量相关的因素。
Aliment Pharmacol Ther. 2023 Feb;57(3):323-334. doi: 10.1111/apt.17356. Epub 2022 Dec 21.

引用本文的文献

1
The Impact of Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) on Health-Related Quality of Life (HRQoL): Elicitation of Health State Utility Values Through Time Trade-Off (TTO) and EQ-5D.活化磷脂酰肌醇3-激酶δ综合征(APDS)对健康相关生活质量(HRQoL)的影响:通过时间权衡法(TTO)和EQ-5D得出健康状态效用值
Adv Ther. 2025 Jun 21. doi: 10.1007/s12325-025-03252-1.
2
Neurogastroenterology and motility disorders in patients with cirrhosis.肝硬化患者的神经胃肠病学与动力障碍
Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000622. eCollection 2025 Jan 1.
3
Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study.

本文引用的文献

1
Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials.肠易激综合征的药物治疗:随机对照试验的系统评价
Ann Intern Med. 2000 Jul 18;133(2):136-47. doi: 10.7326/0003-4819-133-2-200007180-00013.
2
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial.阿洛司琼治疗肠易激综合征女性患者的疗效与安全性:一项随机、安慰剂对照试验
Lancet. 2000 Mar 25;355(9209):1035-40. doi: 10.1016/S0140-6736(00)02033-X.
3
Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome.
经济评估中估计生产力损失方法的考察:以食源性疾病为例
Pharmacoeconomics. 2025 Apr;43(4):453-467. doi: 10.1007/s40273-024-01458-9. Epub 2025 Jan 4.
4
Examining interactions of illness perceptions, avoidance behavior and patient status in predicting quality of life among people with irritable bowel syndrome.研究疾病认知、回避行为和患者状态之间的相互作用对肠易激综合征患者生活质量的预测作用。
Health Psychol Behav Med. 2024 Feb 5;12(1):2311986. doi: 10.1080/21642850.2024.2311986. eCollection 2024.
5
Low-level inflammation, immunity, and brain-gut axis in IBS: unraveling the complex relationships.IBS 中的低水平炎症、免疫和脑肠轴:揭示复杂的关系。
Gut Microbes. 2023 Dec;15(2):2263209. doi: 10.1080/19490976.2023.2263209. Epub 2023 Oct 2.
6
Multi-omics for biomarker approaches in the diagnostic evaluation and management of abdominal pain and irritable bowel syndrome: what lies ahead.多组学在腹痛和肠易激综合征的诊断评估和管理中的生物标志物方法:未来的方向。
Gut Microbes. 2023 Jan-Dec;15(1):2195792. doi: 10.1080/19490976.2023.2195792.
7
The efficacy of vitamin D supplementation for irritable bowel syndrome: a systematic review with meta-analysis.维生素 D 补充剂治疗肠易激综合征的疗效:系统评价与荟萃分析。
Nutr J. 2022 May 5;21(1):24. doi: 10.1186/s12937-022-00777-x.
8
Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.英国罗马 IV 或罗马 III 定义的肠易激综合征的直接医疗成本。
Aliment Pharmacol Ther. 2022 Jul;56(1):110-120. doi: 10.1111/apt.16939. Epub 2022 May 1.
9
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population.普通人群中罗马 IV 肠易激综合征患者的医疗保健利用情况。
United European Gastroenterol J. 2021 Dec;9(10):1178-1188. doi: 10.1002/ueg2.12153. Epub 2021 Oct 1.
10
A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome.一种新颖的分步综合分析管道揭示了不同的微生物群-宿主相互作用,并与肠易激综合征的症状相关联。
Sci Rep. 2021 Mar 9;11(1):5521. doi: 10.1038/s41598-021-84686-9.
替加色罗可加速以便秘为主的肠易激综合征患者的口盲肠转运。
Gastroenterology. 2000 Mar;118(3):463-8. doi: 10.1016/s0016-5085(00)70251-4.
4
The health economic impact of upper gastrointestinal symptoms in the general population: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST).普通人群中上消化道症状的健康经济影响:国内/国际胃肠病学监测研究(DIGEST)的结果
Scand J Gastroenterol Suppl. 1999;231:38-47. doi: 10.1080/003655299750025255.
5
Generic and condition-specific outcome measures for people with osteoarthritis of the knee.膝骨关节炎患者的通用及特定病情结局指标
Rheumatology (Oxford). 1999 Sep;38(9):870-7. doi: 10.1093/rheumatology/38.9.870.
6
Recommendations for the management of irritable bowel syndrome in family practice. IBS Consensus Conference Participants.家庭医疗中肠易激综合征的管理建议。肠易激综合征共识会议参与者。
CMAJ. 1999 Jul 27;161(2):154-60.
7
EuroQol: the current state of play.欧洲生活质量量表:当前进展情况
Health Policy. 1996 Jul;37(1):53-72. doi: 10.1016/0168-8510(96)00822-6.
8
EuroQol--a new facility for the measurement of health-related quality of life.欧洲生活质量量表——一种衡量健康相关生活质量的新工具。
Health Policy. 1990 Dec;16(3):199-208. doi: 10.1016/0168-8510(90)90421-9.
9
Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom.肠易激综合征对美国和英国生活质量及资源利用的影响。
Digestion. 1999 Jan-Feb;60(1):77-81. doi: 10.1159/000007593.
10
Clinical economics review: irritable bowel syndrome.临床经济学综述:肠易激综合征
Aliment Pharmacol Ther. 1997 Dec;11(6):1019-30. doi: 10.1046/j.1365-2036.1997.00262.x.